Abstract:Yan He, 1, &ast Yulei Tang, 1, &ast Silu Wen, 1 Lin Dong, 1 Fen Li, 1, 2 Yuqing Deng, 1 Zezhang Tao 1 1 Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China; 2 Research Institute of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zezhang Tao; Yuqing Deng, Email ; Background: Allergic rhinitis (AR) is globally recognized as a considerable threat to human health with a rising prevalence and a substantial medical and socioeconomic burden. Numerous studies have emphasized the significance of long noncoding RNAs (lncRNAs) in allergic responses. Hence, this research dealt with exploring the involvement of the lncRNA LINC00998 in the mechanism of AR. Methods: LINC00998 expression was assessed by qRT-PCR in peripheral blood mononuclear cells acquired from individuals with AR. Additionally, the potential relationship between LINC00998 and macrophage polarization was observed in vitro. Then we constructed AR mice model and macrophage polarization models using THP-1 cells as well as primary human macrophages to verify the M2 shift in AR and the low expression level of LINC00998 in M2 macrophages. We used gain- and loss-of-function experiments to explore the modification of LINC00998 in macrophage polarization. Furthermore, we explored the underlying mechanism of LINC00998 mediates through qRT-PCR, flow cytometry, and Western blot. Results: The analysis revealed a significant decrease in LINC00998 expression in the samples obtained from patients with AR. LINC00998 is markedly increased in M1 macrophages whereas decreased in M2 macrophages in vitro. Furthermore, suppression of LINC00998 caused a remarkable enhancement in M2 polarization, whereas its overexpression led to its attenuation. Knockdown of LINC00998 led to a remarkable downregulation of BOB.1 mRNA and protein, while overexpression of LINC00998 upregulated their expression. Moreover, it was found that BOB.1 modulated macrophage polarization through the PU.1/IL-1β axis. Meanwhile, the modulation of LINC00098 overexpression on macrophage polarization and PU.1/ IL-1β can be reversed by BOB.1 siRNA. Conclusion: This research revealed the lncRNA LINC00998 altered M2 macrophage polarization by regulating the BOB.1/PU.1/IL-1β axis, which open up new avenues for studying the pathogenesis of AR. Keywords: allergic rhinitis, allergy, macrophage polarization, LncRNA, LINC00998 Graphical Allergic rhinitis (AR), one of the most prevalent diseases globally, affects an estimated 10 to 40% of people worldwide. 1 AR is characterized by clinical symptoms like paroxysmal sneezing, nasal itching, nasal congestion, and a runny nose, all of which significantly impair quality of life. 2 Various treatments, including intranasal cortico-steroids (ICS), antihistamines, and allergen immunotherapy, have been constantly developed to alleviate these symptoms. 3 However, a complete cure for AR remains elusive, and the underlying pathological mechanism is still poorly understood. AR is a chronic, non-infectious inflammatory condition strongly associated with "type 2" immune responses characterized by cytokines such as interleukin-4 (IL-4) and IL-13. 4 To further comprehend the molecular mechanisms underlying AR and identify new targets for treatment, it is crucial to identify the primary pathogenic molecules implicated in the pathogenesis of AR. Immunity and tissue repair are among the many biological and pathological processes that macrophages contribute to. However, they can also contribute to tissue damage when activated inappropriately during inflammation response. 5 Similar to Th1/Th2 polarization, uncommitted macrophages (M0) can polarize into classically activated M1 macrophages or alternatively activated M2 macrophages triggered by specific microenvironment exposure. 6 The M1 phenotype is stimulated by Th1 cytokines such as interferon-gamma (IFN-γ) or tumor necrosis factor-α (TNF-α), as well as some pathogen-associated molecular patterns like lipopolysaccharide (LPS). Conversely, M2 macrophages are stimulated by IL-4 or IL-13 stimulation. 7 Phenotypically, M1 macrophages are characterized by enhanced expression of pro-inflammatory Th1 cytokines (IL-1β, IL-6, and IL-12) and major histocompatibility complex (MHC) class II molecules. Conversely, M2 macrophages exhibit high levels of CD206, ARG1, and CD163. 8 Dysregulation of the M1/M2 equilibrium is often a -Abstract Truncated-

Mir-511-3p Limits Allergic Inflammation Through M2 Macrophage Polarization And Modulating Ccl2 Expression

MiR-127 Modulates Macrophage Polarization and Promotes Lung Inflammation and Injury by Activating the JNK Pathway

Mannose receptor modulates macrophage polarization and allergic inflammation through miR-511-3p

MIR222HG attenuates macrophage M2 polarization and allergic inflammation in allergic rhinitis by targeting the miR146a-5p/TRAF6/NF-κB axis

Mir-202-5p Promotes M2 Polarization In Allergic Rhinitis By Targeting Matn2

Effect of miR-506-3p on Proliferation and Apoptosis of Airway Smooth Muscle Cells in Asthmatic Mice by Regulating CCL2 Gene Expression and Mediating TLR4/NF-κB Signaling Pathway Activation

Down-Regulation of Mir-146A Expression Induces Allergic Conjunctivitis in Mice by Increasing TSLP Level

MicroRNA Mediated Chemokine Responses in Human Airway Smooth Muscle Cells

Enhanced Local Foxp3 Expression in Lung Tissue Attenuates Airway Inflammation in A Mouse Model of Asthma

Microrna-22-3p Plays A Protective Role In A Murine Asthma Model Through The Inhibition Of The Nlrp3-Caspase-1-Il-1 Beta Axis

Microrna-106b Regulates Pro-Allergic Properties of Dendritic Cells and Th2 Polarisation by Targeting Early Growth Response-2 in Vitro

MicroRNA-214-3p facilitates M2 macrophage polarization by targeting GSK3B

Effective delivery of miR-511-3p with mannose-decorated exosomes with RNA nanoparticles confers protection against asthma

Pulmonary Microrna Profiles Identify Involvement of Creb1 and Sec14l3 in Bronchial Epithelial Changes in Allergic Asthma

Interfering with alternatively activated macrophages by CSF-1R inhibition exerts therapeutic capacity on allergic airway inflammation

Intranasal Administration of Lentiviral miR-135a Regulates Mast Cell and Allergen-Induced Inflammation by Targeting GATA-3

MiR-200a and miR-200b restrain inflammation by targeting ORMDL3 to regulate the ERK/MMP-9 pathway in asthma

A Synthetic Toll-Like Receptor 2 Ligand Decreases Allergic Immune Responses in a Mouse Rhinitis Model Sensitized to Mite Allergen

LINC00998 Modulating M2 Macrophage Activation in Allergic Rhinitis by Stabilizing BOB.1 mRNA

IL-16 regulates macrophage polarization as a target gene of mir-145-3p

MiR-150-5p regulates the functions of type 2 innate lymphoid cells via the ICAM-1/p38 MAPK axis in allergic rhinitis